Dynamin inhibitors are compounds that block the action of dynamin proteins in cells. Dynamin is involved in vesicle formation and membrane trafficking. By inhibiting dynamin, these compounds can affect processes like endocytosis. Researchers study dynamin inhibitors to understand their potential in treating diseases like cancer and neurodegenerative disorders, where disrupted cellular processes play a role.